Krka UK has announced the launch of Robexera® 20 mg/ml injectable solution, the first generic robenacoxib injectable available in the UK. Robexera® gives clinicians access to a more affordable, highly COX-2 selective injectable non-steroidal anti-inflammatory drug (NSAID), indicated for the targeted control of perioperative pain and inflammation in cats and dogs.

Veterinary professionals are invited to explore the latest advances in gut health and pet nutrition at the Purina® PRO PLAN® Symposium,the official pre-symposium of the Eurogut Congress 2026. The symposium, titled ‘Navigating Microbiota Dynamics Applicable to Pet Nutrition’, will be held on 6th May and will explore how microbiota science is shaping the future of gut health an...

The Animal Health Professions’ Register (AHPR) has reaffirmed its position as a leading voice for musculoskeletal (MSK) practitioners in shaping future legislation, following the close of Defra’s consultation on Veterinary Surgeons Act (VSA) reform last week.

BreathEazy, a veterinary-led provider of respiratory care solutions, has launched a new podcast, Between the Reins, exploring the science and management of equine respiratory health and performance.

The first episode brings together equine veterinary surgeon Fi...

Krka UK has launched Prazemo®, a spot-on wormer for cats, expanding its companion animal parasite control offering for the treatment of key feline endoparasites.

Prazemo® combines emodepside and praziquantel to target roundworms, hookworms, lungworms and tapeworms. As the first generic solution to market of this active combination format, Prazemo® is bioequivalent t...